English  |  正體中文  |  简体中文  |  總筆數 :2830311  
造訪人次 :  32571538    線上人數 :  508
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"ky hsu"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-10 / 14 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺北醫學大學 2014 A relative bioavailability study of 500mg calcium p-aminosalicylate film coating tablet in healthy individuals Cheng, Cheng C;ML, Chen;Tseng, C;YS, Ueng;CL, Huang;KY, Hsu
臺北醫學大學 2014 Pharmacokinetics of fexofenadine in healthy Taiwanese volunteers YA, Chen;KY, Hsu
臺北醫學大學 2014 Development and validation of an in vitro-in vivo correlation(IVIVC) model for propranolol hydrochloride extended-release matrix formulations Cheng, Cheng C;PC, Wu;HY, Lee;KY, Hsu
臺北醫學大學 2014 Facile method for determination of deoxycytidine kinase activity in biological milieus WH, Hao;LC, Yang;JJ, Wang;CS, Hsu;LC, Chang;KY, Hsu
臺北醫學大學 2013 Determination of fexofenadine in human plasma by LC-MS/MS and its application in pharmacokinetic study YA, Chen;HY, Chou;WK, Chang;KY, Hsu
臺北醫學大學 2013 Development of a LC–MS/MS-based method for determining metolazone concentrations in human plasma:Application toa pharmacokinetic study YA, Chen;KY, Hsu
臺北醫學大學 2013 Development of a Taiwan Version of the Eight-item Morisky Medication Adherence Scale and Factors Influencing Patients' Comprehension YS, Lin;Ho, Y;WW, Su;KY, Hsu;WW, Shen;CC, Chiueh;RY, Yuan
臺北醫學大學 2012 Proteome analysis of altered proteins in streptozotocin-induced diabetic rat kidney using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method PY, Tsai;SM, Chen;HY, Chen;YC, Li;Imai, K;KY, Hsu;JA, Lee
臺北醫學大學 2012 In vitro and in vivo studies of pkarmacokinetics and antitumor efficacy of D07001-F4, an oral gemcitabine formulation WH, Hao;JJ, Wang;SP, Hsueh;PJ, Hsu;LC, Chang;CS, Hsu;KY, Hsu
臺北醫學大學 2011 Pharmacokinetics of felodipine extended-release tablets in healthy Taiwan subjects:a retropective review CL, Hsiao;YC, Wu;KY, Hsu

顯示項目 1-10 / 14 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目